Trisalus Life Sciences Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Trisalus Life Sciences Inc inventory turnover ratio, the Trisalus Life Sciences Inc 's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 1.72 in the first quarter 2026, a new company high. Average inventory processing period, for the Trisalus Life Sciences Inc in Mar 31 2026 quarter, has decreased to 212 days, compare to 217 days, in the Dec 31 2025 quarter.

Within Healthcare sector 228 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2026, to 1356, from total ranking in the fourth quarter 2025 at 1577.

TLSI Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Trisalus Life Sciences Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

TLSI Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	-9.23 %	-23.99 %	-18.08 %	10.57 %	42.88 %
Y / Y Cost of Sales Growth	0 %	168.58 %	0 %	9.65 %	2.99 %
Inventory Turnover Ratio (TTM)	1.72	1.68	1.08	1.03	1.03
TLSI's Total Ranking	# 1356	# 1577	# 1577	# 1600	# 1689
Average inventory processing period	212	218	339	355	354
Seq. Inventory Growth	22.78 %	-6.07 %	-13.95 %	-8.53 %	2.82 %
Seq. Cost of Sales Growth	-66.67 %	200 %	0 %	0 %	-10.47 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 100
Healthcare Sector	# 229
Overall Market	# 1356

Inventory Turnover Ratio Statistics
High	Average	Low
1.72	1.31	1.03
(Mar 31 2026)		(Jun 30 2025)

TLSI Company Profile >> Back to TLSI Efficiency Comparisons >> Compare TLSI Inventory Turnover Ratio to its Competitors

Financial Statements
Trisalus Life Sciences Inc 's Inventories	$ 4 Millions	Visit TLSI's Balance sheet
Trisalus Life Sciences Inc 's Cost of Revenues TTM	$ 6 Millions	Visit TLSI's Income Statement
What are TLSI's Sales?		Visit TLSI's Sales by Segment

Other Inventory Turnover Ratios
Trisalus Life Sciences Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
TLSI's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for TLSI's Competitors
Inventory Turnover Ratio for TLSI's Suppliers
Inventory Turnover Ratio for TLSI's Customers

You may also want to know
TLSI's Sales Growth Rates	TLSI's Pe Price to earnings ratio	TLSI's Receivables Turnover Ratio	TLSI's Stock Quote
TLSI's Net Income Growth Rates	TLSI's Ps Price to Sales ratio	TLSI's Sales per Employee	TLSI's Asset Turnover Ratio
TLSI's Net Margin	TLSI's Pb Price to Book ratio	TLSI's Financial Strength Ratios	TLSI's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
Envista Holdings Corporation	4.36	$ 1,267.000 Millions	$ 290 Millions
Inotiv Inc	4.25	$ 175.895 Millions	$ 41 Millions
Cryoport inc	4.23	$ 96.609 Millions	$ 23 Millions
Teva Pharmaceutical Industries Limited	4.22	$ 8,317.000 Millions	$ 1,971 Millions
Incyte Corporation	4.21	$ 403.465 Millions	$ 96 Millions
Electromed Inc	4.16	$ 14.195 Millions	$ 3 Millions
Vericel Corporation	4.15	$ 73.494 Millions	$ 18 Millions
Sharps Technology Inc	4.12	$ 3.585 Millions	$ 1 Millions
Coherus Oncology inc	4.11	$ 14.975 Millions	$ 4 Millions
Novocure Limited	4.08	$ 167.287 Millions	$ 41 Millions
Lifeward ltd	4.08	$ 13.275 Millions	$ 3 Millions
Ge Healthcare Technologies Inc	4.04	$ 9,262.000 Millions	$ 2,294 Millions
Koru Medical Systems Inc	3.99	$ 16.468 Millions	$ 4 Millions
3m Company	3.94	$ 15,087.000 Millions	$ 3,830 Millions
Iridex Corp	3.92	$ 32.247 Millions	$ 8 Millions
Myomo Inc	3.88	$ 14.000 Millions	$ 4 Millions
Elite Pharmaceuticals Inc	3.84	$ 71.976 Millions	$ 19 Millions
Escalon Medical Corp	3.79	$ 6.698 Millions	$ 2 Millions
Evolus Inc	3.71	$ 103.000 Millions	$ 28 Millions
Abbvie Inc	3.70	$ 18,420.000 Millions	$ 4,975 Millions
Alpha Teknova Inc	3.69	$ 26.248 Millions	$ 7 Millions
Biocryst Pharmaceuticals Inc	3.67	$ 19.884 Millions	$ 5 Millions
Neuraxis Inc	3.61	$ 0.665 Millions	$ 0 Millions
Mirum Pharmaceuticals Inc	3.50	$ 85.221 Millions	$ 24 Millions
Sonoma Pharmaceuticals Inc	3.46	$ 12.114 Millions	$ 4 Millions
Tandem Diabetes Care Inc	3.45	$ 461.746 Millions	$ 134 Millions
Exelixis Inc	3.41	$ 84.478 Millions	$ 25 Millions
Baxter International Inc	3.37	$ 7,911.000 Millions	$ 2,348 Millions
Gilead Sciences Inc	3.36	$ 6,139.000 Millions	$ 1,825 Millions
Maravai Lifesciences Holdings Inc	3.33	$ 143.875 Millions	$ 43 Millions

Date modified: 2026-08-29T17:43:44+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.